This Week on NeurologyLive

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

The 15th segment of our recently released Insights series, "The Changing Treatment Landscape for Acute Migraine," goes live on Monday, November 2, 2020. The series features David Dodick, MD, and Robert Cowan, MD, FAAN, as they review the recent changes in the treatment paradigm. In the final segment, Cowan discusses the upcoming studies for the treatment of acute migraine, including some promising devices.

To check out the whole series, click here.

Our new Q&A series dedicated to conversations with leaders in the neurology community, called NeuroVoices, features insight from Joe Verghese, MBBS, MS, on the recent grant he was awarded by the National Institutes of Health (NIH) for studies on prevention and treatment of Alzheimer disease. Verghese, the director of the Montefiore Einstein Center for the Aging Brain, detailed both studies and their individual goals on both motors cognitive risk syndrome and non-invasive brain stimulation, respectively.

To check out the prior NeuroVoices conversations, click here.

A conversation with Leigh Charvet, PhD, clinical neuropsychologist, and associate professor, Department of Neurology, NYU Grossman School of Medicine​, will air on NeurologyLive's segment on the Medical World News channel this Thursday, November 5, 2020. Charvet discussed the current state of digital therapy in multiple sclerosis (MS), and how the recent increase in telemedicine has opened the door for practice-changing, digital-based care.

To check out our latest coverage of MS news, click here.

Episode 21 of the NeurologyLive "Mind Moments" podcast will air on Friday, November 6, 2020. The episode will feature an exclusive interview with Indu Subramanian, MD, director, VA Southwest Parkinson’s Disease Research, Education, and Clinical Centers, and staff, Department of Neurology, UCLA. She discussed how loneliness can impact Parkinson disease severity and how holistic approaches to care, such as social prescribing, may help address this problem.

To subscribe on your favorite podcast player, click here.

Another segment from the “Rapid Readout: Expert Perspectives on Multiple Sclerosis” News Network series featuring Mark Freedman, MD, MSc, will publish this week. Freedman covers the exciting takeaways from the 8th Joint meeting of ACTRIMS and ECTRIMS meeting, including the utility of serum biomarkers of disease activity. He also provides insight on a study that examined 2 different doses of masitinib in patients with primary progressive multiple sclerosis.

To check out the whole series, click here.